ClinicalTrials.Veeva

Menu

Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis

G

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Status

Unknown

Conditions

Arthritis, Rheumatoid

Treatments

Drug: Luo-Fu-Shan Plaster
Drug: The placebo 10g

Study type

Interventional

Funder types

Other

Identifiers

NCT04884880
2020006P4A01

Details and patient eligibility

About

The aim of this study is to assess the efficacy and safety of Luo-Fu-Shan Plaster in patients with Rheumatoid Arthritis.

Full description

The investigators are inspired by Chinese traditonal herb, an therapy for thousands of years, and take its advantage to make Luo-Fu-Shan Plaster in order to get an effective and safe treatment for active RA patients. The study is a multicenter, randomized, double-blind, placebo-controlled trial.

Enrollment

180 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female subjects aged 18 to 75 years (time of get informed consent)
  • Documented diagnosis of rheumatoid arthritis, as defined by the American Rheumatism Association 1987 Revised Criteria.
  • Documented diagnosis of damp-heat syndrome according to Traditional Chinese Medicine.
  • If patients are receiving Disease-modifying anti-rheumatic drugs (DMARDs), then the doses should have been kept stable for at least 12 weeks.
  • If patients are receiving non-steroidal anti-inflammatory drugs (NSAIDs) or orally Chinese herbal medicine, then the doses should have been kept stable for at least 4 weeks.

Exclusion criteria

  • Skin allergies or broken skin;
  • Taking glucocorticoids,more than 10 mg daily.
  • Female patients who are pregnant, breast-feeding or planed to be pregnant;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 2 patient groups, including a placebo group

Luo-Fu-Shan Plaster 10g
Experimental group
Description:
10g,once daily,4 weeks
Treatment:
Drug: Luo-Fu-Shan Plaster
Placebo
Placebo Comparator group
Description:
10g,once daily,4 weeks
Treatment:
Drug: The placebo 10g

Trial contacts and locations

1

Loading...

Central trial contact

Jiang Quan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems